This study aims to assess the prevalence and severity of depression, anxiety, and sleep disorders among patients with idiopathic Parkinson's disease. The study will evaluate the relationship between neuropsychiatric symptoms and disease characteristics in order to improve early recognition and patient quality of life.
Study Type
OBSERVATIONAL
Enrollment
100
Assessment of Depression Severity in Patients with idiopathic Parkinson's Disease
Depression severity measured using the Hamilton Depression Rating Scale (HAM-D). Scores range from 0 to 52, with higher scores indicating more severe depression.
Time frame: Baseline assessment during study enrollment.
Assessment of Anxiety Severity in Patients with idiopathic Parkinson's Disease
Anxiety severity measured using the Hamilton Anxiety Rating Scale (HAM-A). Scores range from 0 to 56, with higher scores indicating more severe anxiety.
Time frame: Baseline
Assessment of Sleep Disturbance in Patients with idiopathic Parkinson's Disease
Sleep disturbance measured using the Parkinson's Disease Sleep Scale (PDSS). Higher scores indicate better sleep quality and fewer sleep-related symptoms.
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.